Skip to content

Midema

Active Private limited companyfounded 2020active for 6 yearsJokeven 3, 2370 ArendonkKBO/BCE: BE 0755.545.272

Lifetime

5 annual accounts with figures on one time axis
peak of €304,667 in 2025
€304,667▲ 61.1%
peak of €209,244 in 2025
€209,244▲ 57.2%
peak of €146,239 in 2023
€29,370unchanged
€329,046▲ 11.5%
Board1 name since 2020
1 director
Documentsfilings and deeds
23-06-202638 days before the deadline
2025micro format
Gross margin from €189,109 to €304,667Result from €133,131 to €209,244Dividend €209,244Investments €99,174Cash from €172,658 to €80,811

Key points

from the 2025 annual accounts

Equity

€29,370 from €146,239 in 2023

Equity fell by 80% in 2 years.

Result

€209,244 ▲ 57.2%
€133,0002024€209,0002025

The result rose in 2025 from €133,131 to €209,244.

Turnover

≈ €450,000 estimated

The micro format states no turnover.

Debts

€329,046 92% of the balance sheet
Financial debts 18%Suppliers 2%Taxes and wages 10%Other 70%

Of this, €269,985 falls due within a year.

Investments

€99,174 7.7 times depreciation
2022202320242025

Green is investment, beige is depreciation.

Position in the sector

8.2%

Lower solvency than 87% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Midema has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Midema. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 400 sharesdeed of 05-10-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0755545272
Registered office moved within Arendonk The registered office moved from Jokeven 1, 2370 Arendonk to Jokeven 3, 2370 Arendonk · Board meeting of 01-01-2022 · Gazette deed
Incorporation Founding capital of €4,000, 400 shares · Founded by · appointed as director · published on 05-10-2020 · Gazette deed
First establishment Jokeven 3, Arendonk
All 13 events

Comparable companies

same main activity, similar in size and age
Company
Midema Arendonk €358,416 €304,667 8.2% -
Röntgenium Roeselare €323,198 €279,832 26.9% -
Yannick Wouters Herentals €265,536 €380,413 1.1% -
ArteMedicale Ghent €468,601 €257,025 39.8% -
Upsports Zaventem €279,662 €242,005 15.1% -
Mélanie Monfort Bio Clin Verlaine €379,544 €391,290 2.2% -
TECHNOLOGUE IMAGERIE MEDICALE SERVICES Villers-la-Ville €460,120 €311,054 32.4% -

These companies have the same main activity as Midema: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €266,000 and €469,000, founded between 2019 and 2022.

Official details

Source: KBO
Status
Active since 01-10-2020Normal situation
Activity
Medical imaging and medical laboratoriesNACE 86910and 2 others
Establishment unit
2.307.947.8232370 Arendonk, since 01-10-2020
Financial year end
31 December
Peppol
Reachable since 20-08-2025
Company details

Annual accounts 2025

€358,416▲ 10.4%
Filing
Filed on 23-06-2026, 38 days before the end of the filing period
Financials

Insights on Midema

Midema files the micro format. That format states no turnover. The gross margin rose from €82,262 in 2021 to €304,667 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Midema

What is the company number of Midema?
The company number of Midema is 0755.545.272. The VAT number is the same number with BE in front: BE 0755.545.272.
Where is Midema based?
The registered office is at Jokeven 3, 2370 Arendonk.Company details
What does Midema do?
According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
What is the legal form of Midema?
Midema is a private limited company (BV).
When was Midema founded?
Midema was founded on 01-10-2020.
Is Midema still active?
Yes, Midema is an active enterprise in the KBO register.
What is the turnover of Midema?
The turnover in financial year 2025 is about €450,000. This figure is estimated from the gross margin of €304,667 and 48 comparable companies (NACE 86). It probably lies between €370,000 and €570,000.Financials
Is Midema profitable?
In financial year 2025, Midema made a profit of €209,244.
Where can I find the annual accounts of Midema?
Midema filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Midema due?
Midema must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.